Description
cirmtuzumab, CAS: 2485779-13-1
Targets
Neurotrophic tyrosine kinase, receptor-related 1, Inactive tyrosine-protein kinase transmembrane receptor ROR1, NTRKR1, ROR1
Isotype/Mimetic
IgG1-Kappa
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Unknown
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Unknown discovery source/method, In vitro recombinant expression